Fundraising Fox

Nexo Therapeutics, Inc.

Littleton, US · Founded 2022 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

AP
Andrew PhillipsExecutive

Board

ABAli Behbahani
Ali BehbahaniinBoard directorPartner, Co-Head of Healthcare at New Enterprise Associates (NEA)
CRCarlo Rizzuto
Carlo Rizzutoin𝕏Board directorManaging Director at Versant Ventures

Investors · 2

New Enterprise Associates (NEA)reportedMenlo Park · $200K – $40Mvia Ali Behbahani · board
Versant VenturesreportedSan Francisco · $250K – $5Mvia Carlo Rizzuto · board

Reported raises · per SEC filings

Form D private placements

$60M disclosed across 1 round · 2022

▶$60MraisedMar 2026 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Ali BehbahaniDirector
  • Andrew PhillipsExecutive Officer, Director
  • Carlo RizzutoDirector
Offering amount
$60M
Amount sold
$60M
First sale
Nov 2022
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Nexo Therapeutics, Inc.'s investors?
Nexo Therapeutics, Inc.'s investors include New Enterprise Associates (NEA), Versant Ventures.
How much funding has Nexo Therapeutics, Inc. raised?
Nexo Therapeutics, Inc. has disclosed $60M raised across 1 round.
Where is Nexo Therapeutics, Inc. headquartered?
Nexo Therapeutics, Inc. is headquartered in Littleton, US.